Your browser doesn't support javascript.
loading
Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccines and breakthrough infected individuals.
Tan, Chee Wah; Lim, Chuan Kok; Prestedge, Jacqueline; Batty, Mitchell; Mah, Yun Yan; O'Han, Michelle; Wang, Lin-Fa; Kilby, Dean; Anderson, Danielle E.
Afiliação
  • Tan CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, 169857, Singapore.
  • Lim CK; Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117547, Singapore.
  • Prestedge J; Victorian Infectious Diseases Reference Laboratory, Melbourne Health, The Peter Doherty Institute for Infection and Immunity, Melbourne, 3000, Australia.
  • Batty M; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, 3000, Australia.
  • Mah YY; Victorian Infectious Diseases Reference Laboratory, Melbourne Health, The Peter Doherty Institute for Infection and Immunity, Melbourne, 3000, Australia.
  • O'Han M; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, 3000, Australia.
  • Wang LF; Victorian Infectious Diseases Reference Laboratory, Melbourne Health, The Peter Doherty Institute for Infection and Immunity, Melbourne, 3000, Australia.
  • Kilby D; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, 3000, Australia.
  • Anderson DE; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, 169857, Singapore.
Sci Rep ; 13(1): 20263, 2023 11 20.
Article em En | MEDLINE | ID: mdl-37985674
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Singapura
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Singapura